Successful treatment of recalcitrant mucous membrane pemphigoid with multisystem involvement with baricitinib and methotrexate

Kevin M Burningham; Jennifer Cao; Arturo R Dominguez

doi:10.1016/j.jdcr.2022.07.013

Successful treatment of recalcitrant mucous membrane pemphigoid with multisystem involvement with baricitinib and methotrexate

JAAD Case Rep. 2022 Jul 16:27:67-69. doi: 10.1016/j.jdcr.2022.07.013. eCollection 2022 Sep.

Authors

Kevin M Burningham¹, Jennifer Cao², Arturo R Dominguez³

Affiliations

¹ UT Southwestern School of Medicine, UT Southwestern Medical Center, Dallas, Texas.
² Department of Ophthalmology, UT Southwestern Medical Center, Dallas, Texas.
³ Departments of Dermatology and Internal Medicine, UT Southwestern Medical Center, Dallas, Texas.

No abstract available

Keywords: IVIG, intravenous immunoglobulin; JAK inhibitors; JK, Janus kinas; MMP, mucous membrane pemphigoid; TNF, tumor necrosis factor; autoimmune blistering skin disease; baricitinib; cicatricial pemphigoid; conjunctiva; esophageal mucosa; methotrexate; mouth mucosa; mucous membrane pemphigoid; ocular cicatricial pemphigoid; oral ulcers; tongue.

Publication types

Case Reports